Skip to main content

Xeris Biopharma Holdings, Inc.

XERS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001867096

In the last 90 days, Xeris Biopharma Holdings, Inc. insiders filed 0 open-market purchases and 10 sales; 242 institutions reported holding it in 13F filings for Q2 2026, worth $857.1M in total; no superinvestor holds it.

Q4 2025 vs. Q3 2025

How the institutions holding Xeris Biopharma Holdings, Inc. changed between Q3 2025 and Q4 2025.

All holders in Q4 2025All holders in Q3 2025

13F holders of XERS: Q3 2025 compared with Q4 2025
MeasureQ3 2025Of which not filed for Q4 2025Q4 2025Change
Holders2311227−3
Shares97.0M16.4K100.9M+3.95M (+4.1%)
Value$789.3M$133.2K$792.0M+$2.83M (+0.4%)

1 institution that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (35)

Institutions that held Xeris Biopharma Holdings, Inc. at the end of Q4 2025 but not at the end of Q3 2025.

Institutions new to XERS in Q4 2025
InstitutionSharesValue% of portfolio
Norges Bank800,700$6.29M0.00%
Ishara Investments LP800,000$6.28M7.31%
Point72 Asset Management, L.P.608,080$4.77M0.01%
Castleark Management LLC445,950$3.50M0.10%
Voss Capital, LLC371,709$2.92M0.16%
Arrowstreet Capital, Limited Partnership214,786$1.69M0.00%
Ambassador Advisors, LLC106,730$837.8K0.12%
Resolute Capital Asset Partners LLC100,000$785.0K0.38%
Jefferies Financial Group Inc.87,800$689.2K0.01%
Western Wealth Management, LLC75,675$594.0K0.03%
Teachers Retirement System of the State of Kentucky72,907$572.0K0.00%
Integrated Quantitative Investments LLC66,170$519.4K0.11%
Penn Capital Management Co Inc48,064$377.3K0.03%
Man Group plc47,775$375.0K0.00%
AlphaCentric Advisors LLC43,392$340.6K0.34%
Ausbil Investment Management Ltd37,000$290.4K0.17%
VARCOV Co.31,005$243.4K0.10%
Fox Run Management, L.L.C.26,174$205.5K0.03%
Swiss Life Asset Management Ltd26,059$204.6K0.00%
9823 Capital, L.P.24,917$195.6K0.13%
Dynamic Technology Lab Private Ltd17,200$135.0K0.03%
Bailard, Inc.15,300$120.1K0.00%
Skopos Labs, Inc.12,195$90.6K0.00%
Jain Global LLC11,114$87.2K0.00%
CIBC World Markets Corp10,158$79.7K0.00%
Kingsview Wealth Management, LLC10,000$78.5K0.00%
Kemnay Advisory Services Inc.8,480$66.6K0.01%
Kestra Advisory Services, LLC3,192$25.1K0.00%
BNP PARIBAS ASSET MANAGEMENT Holding S.A.2,353$18.0K0.00%
Sound Income Strategies, LLC1,149$8.64K0.00%
Rockefeller Capital Management L.P.594$4.66K0.00%
Smartleaf Asset Management LLC225$1.65K0.00%
Atlantic Private Wealth, LLC30$2360.00%
MAI Capital Management27$2120.00%
SJS Investment Consulting Inc.19$1500.00%

Sold out (38)

Institutions that held Xeris Biopharma Holdings, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.

Not filed for Q4 2025 yet (1)

Institutions that held Xeris Biopharma Holdings, Inc. at the end of Q3 2025 and haven't filed a 13F for Q4 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding XERS in Q3 2025 that haven't filed for Q4 2025
InstitutionShares, Q3 2025Value, Q3 2025
CIBC Bancorp USA Inc.16,367$133.2K